Differential activation of mast cells by antigens from Trichinella spiralis muscle larvae, adults, and newborn larvae.
Mast cell (MC) hyperplasia and activation are prominent features in Trichinella spiralis infection. Indeed a temporal correlation has been shown between the kinetics of intestinal mastocytosis, release of inflammatory mediators from MC, and adult worm loss, which constitutes a major component of the defense against T. spiralis infection. It is well known that during the intestinal phase of trichinellosis, muscle larvae (ML) and adult worms (AD) enter into contact with the host; however, interaction with MC may also occur during migration of newborn larvae (NBL). Therefore, it is plausible that antigens from these developmental stages could activate MC. We have previously demonstrated by in vitro assays that T. spiralis muscle larval (TSL-1) antigens activate MC through an Ig-independent mechanism leading to the release of histamine, MC protease 5, IL-4 and TNF alpha. In this work we evaluated whether total antigens from AD or NBL could activate unsensitized MC and we compared this activation with the activation seen when MC are stimulated with TSL-1 antigens. MC activation was also tested with affinity chromatography purified antigens from NBL using the monoclonal antibody CE-4 that recognizes NBL surface components. The results obtained in this study showed that AD total extracts and TSL-1 antigens induced the release of histamine but not beta-hexosaminidase from unsensitized MC, suggesting a selective secretion of MC mediators. In contrast, NBL total extracts or purified NBL antigens did not induce the release of either histamine or beta-hexosaminidase from MC. Interestingly, AD and ML are the stages that interact with the host during the intestinal phase of infection. The mechanisms involved in TSL-1 and AD activation of unsensitized MC may function together with other mechanisms of MC activation in host protection against T. spiralis.
Yépez-Mulia
L
L
UIMEIP-Pediatria, IMSS, Mexico.
Montaño-Escalona
C
C
Fonseca-Liñán
R
R
Muñoz-Cruz
S
S
Arizmendi-Puga
N
N
Boireau
P
P
Ortega-Pierres
G
G
D000818:Animals; D000947:Antigens, Helminth / Q000276:immunology* / Q000494:pharmacology; D002478:Cells, Cultured; D004305:Dose-Response Relationship, Drug; D006636:Histamine Release / Q000502:physiology; D007814:Larva; D008297:Male; D008407:Mast Cells / Q000187:drug effects* / Q000502:physiology*; D009132:Muscles / Q000276:immunology; D051381:Rats; D017207:Rats, Sprague-Dawley; D017160:Trichinella spiralis / Q000276:immunology*; D001619:beta-N-Acetylhexosaminidases / Q000378:metabolism
D000947:Antigens, Helminth; D001619:beta-N-Acetylhexosaminidases